Author:
Wirtz Ralph M.,Sihto Harri,Isola Jorma,Heikkilä Päivi,Kellokumpu-Lehtinen Pirkko-Liisa,Auvinen Päivi,Turpeenniemi-Hujanen Taina,Jyrkkiö Sirkku,Lakis Sotiris,Schlombs Kornelia,Laible Mark,Weber Stefan,Eidt Sebastian,Sahin Ugur,Joensuu Heikki
Publisher
Springer Science and Business Media LLC
Reference18 articles.
1. Goldhirsch A, Winer EP, Coates AS, Gelber RD, Piccart-Gebhart M, Thürlimann B et al (2013) Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann Oncol 24:2206–2223
2. Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S et al (2010) American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. Arch Pathol Lab Med 134:907–922
3. Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ et al (2007) American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 25:118–145
4. Polley MY, Leung SC, McShane LM, Gao D, Hugh JC, Mastropasqua MG et al (2013) An international Ki67 reproducibility study. J Natl Cancer Inst 105:1897–1906
5. Varga Z, Diebold J, Dommann-Scherrer C, Frick H, Kaup D, Noske A et al (2012) How reliable is Ki-67 immunohistochemistry in grade 2 breast carcinomas? A QA study of the Swiss Working Group of Breast- and Gynecopathologists. PLoS One 7:e37379
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献